Compare FSBW & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSBW | SLP |
|---|---|---|
| Founded | 1936 | 1996 |
| Country | United States | United States |
| Employees | 537 | N/A |
| Industry | Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.4M | 250.6M |
| IPO Year | 2011 | 1996 |
| Metric | FSBW | SLP |
|---|---|---|
| Price | $40.80 | $13.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $46.00 | $24.00 |
| AVG Volume (30 Days) | 8.1K | ★ 282.8K |
| Earning Date | 04-24-2026 | 04-09-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.29 | 0.26 |
| Revenue | $4,612,000.00 | ★ $59,577,000.00 |
| Revenue This Year | $14.94 | $2.64 |
| Revenue Next Year | $10.47 | $6.01 |
| P/E Ratio | ★ $9.52 | $50.58 |
| Revenue Growth | ★ 44.80 | 10.52 |
| 52 Week Low | $36.72 | $11.09 |
| 52 Week High | $44.22 | $36.43 |
| Indicator | FSBW | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 55.20 | 64.00 |
| Support Level | $39.44 | $12.45 |
| Resistance Level | $40.67 | $13.84 |
| Average True Range (ATR) | 1.16 | 0.77 |
| MACD | 0.30 | 0.25 |
| Stochastic Oscillator | 76.21 | 49.22 |
FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.